Higenamine reduces apoptotic cell death by induction of heme oxygenase-1 in rat myocardial ischemia-reperfusion injury

Apoptosis

Volumn 11, Issue 7, 2006, Pages 1091-1100

  Lee, Young Soo ^a   Kang, Young Jin ^a,c   Kim, Hye Jung ^a   Park, Min Kyu ^a   Seo, Han Geuk ^a   Lee, Jae Heun ^a   Yun Choi, Hye Sook ^b   Chang, Ki Churl ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Yeungnam University College of Medicine   (South Korea)

Author keywords

Apoptosis; Heme oxygenase; Higenamine; Ischemia reperfusion injury

Indexed keywords

CASPASE 3; CYTOCHROME C; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; HIGENAMINE; PROTEIN BAX; PROTOPORPHYRIN ZINC;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DNA STRAND BREAKAGE; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE;

ALKALOIDS; ANIMALS; ANTIOXIDANTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CARDIOTONIC AGENTS; CASPASE 3; CASPASES; CYTOCHROMES C; CYTOCHROMES C2; ENZYME INHIBITORS; GLUTATHIONE; HEME OXYGENASE (DECYCLIZING); IN SITU NICK-END LABELING; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXIDATION-REDUCTION; PEROXYNITROUS ACID; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTOPORPHYRINS; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDROISOQUINOLINES;

EID: 33745826337     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-7110-y     Document Type: Article

References (44)

1. Koren G, Weiss AT, Hasin Y, et al (1985) Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med 313:1384-1389
2. Braunwald E, Cannon CP (1995) Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty. J Am Coll Cardiol 25:30S-37S
3. Ma XL, Weyrich AS, Lefer DJ, et al (1993) Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 72:403-412
4. Hansen PR (1995) Myocardial reperfusion injury: Experimental evidence and clinical relevance. Eur Heart J 16:734-740
5. Maulik N, Engelman RM, Rousou JA, et al (1999) Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation 100:II369-II375
6. Kajstura J, Cheng W, Reiss K, et al (1996) Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74:86-107
7. Vulapalli SR, Chen Z, Chua BH, et al (2002) Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis. Am J Physiol Heart Circ Physiol 283:H688-H694.
8. Fujita T, Toda K, Karimova A, et al (2001) Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 7:598-604
9. Tullius SG, Nieminen-Kelha M, Buelow R, et al (2002) Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation 74:591-598
10. Yet SF, Tian R, Layne MD, et al (2001) Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89:168-175
11. Ko YS, Park MK, Kang YJ, et al (2002) Up-regulation of heme oxygenase-1 expression by cAMP-elevating agents in RAW 264.7 cells. J Appl Pharmacol 10:71-77
12. Kang YJ, Lee YS, Lee GW, et al (1999) Inhibition of activation of nuclear factor kappaB is responsible for inhibition of inducible nitric oxide synthase expression by higenamine, an active component of aconite root. J Pharmacol Exp Ther 291:314-320
13. Chang KC, Lim JK, Park CW (1986) Synthesis of higenamine and its cardiovascular effects in rabbit: Evidence for β-adrenoceptor agonist. Kor J Pharmacol 22:96-104
14. Zingarelli B, Salzman AL, Szabo C (1998) Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 83:85-94
15. Yamashita N, Hoshida S, Otsu K, et al (1999) Monophosphoryl lipid A provides biphasic cardioprotection against ischemia-reperfusion injury in rat hearts. Br J Pharmacol 128:412-418
16. Virag L, Szabo C (1999) Inhibition of poly(ADP-ribose) synthetase (PARS) and protection against peroxynitrite-induced cytotoxicity by zinc chelation. Br J Pharmacol 126:769-777
17. Kahles H, Goring GG, Nordbeck H, et al (1977) Functional behaviour of isolated heart muscle mitochondria after in situ ischemia. Polarographic analysis of mitochondrial oxidative phosphorylation. Basic Res Cardiol 72:563-574
18. Wu B, Ootani A, Iwakiri R, et al (2004) Ischemic preconditioning attenuates ischemia-reperfusion-induced mucosal apoptosis by inhibiting the mitochondria-dependent pathway in rat small intestine. Am J Physiol Gastrointest Liver Physiol 286:G580-G587
19. Galang N, Sasaki H, Maulik N (2000) Apoptotic cell death during ischemia/reperfusion and its attenuation by antioxidant therapy. Toxicology 148:111-118
20. Misao J, Hayakawa Y, Ohno M, et al (1996) Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation 94:1506-1512
21. Zhao ZQ, Nakamura M, Wang NP, et al (2000) Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 45:651-660
22. Kirshenbaum LA, de Moissac D (1997) The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 96:1580-1585
23. Eyssen-Hernandez R, Ladoux A, Frelin C (1996) Differential regulation of cardiac heme oxygenase-1 and vascular endothelial growth factor mRNA expressions by hemin, heavy metals, heat shock and anoxia. FEBS Lett 382:229-233
24. Csonka, Varga E, Kovacs P, et al (1999) Heme oxygenase and cardiac function in ischemic/reperfused rat hearts. Free Radic Biol Med 27:119-126
25. Hangaishi M, Ishizaka N, Aizawa T, et al (2000) Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo. Biochem Biophys Res Commun 279:582-588
26. Foresti R, Goatly H, Green CJ, et al (2001) Role of heme oxygenase-1 in hypoxia-reoxygenation: requirement of substrate heme to promote cardioprotection. Am J Physiol Heart Circ Physiol 281:H1976-H1984
27. Minamino T, Christou H, Hsieh CM, et al (2001) Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci USA 98:8798-8803
28. Bauer M, Bauer I (2002) Heme oxygenase-1: redox regulation and role in the hepatic response to oxidative stress. Antioxid Redox Signal 4:749-758
29. Amon M, Menger MD, Vollmar B (2003) Heme oxygenase and nitric oxide synthasemediate cooling-associated protection against TNF-alpha-induced microcirculatory dysfunction and apoptotic cell death. FASEB J 17:175-185
30. Sato K, Balla J, Otterbein L, et al (2001) Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166:4185-4194
31. Wiesel P, Patel AP, Carvajal IM, et al (2001) Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice. Circ Res 88:1088-1094
32. Bak I, Papp G, Turoczi T, et al (2002) The role of heme oxygenase-related carbon monoxide and ventricular fibrillation in ischemic/reperfused hearts. Free Radic Biol Med 33:639-648
33. Kim DK, Kim JS, Kim JE, et al (2005) Heme oxygenase-1 induction by dieldrin in dopaminergic cells. Neuroreport 16:509-512
34. Meffert MK, haley JE, Schuman EM, et al (1994) Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins. Neuron 13:1225-1235
35. Appleton SD, Chretien ML, McLaughlin BE, et al (1999) Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. Drug Metab Dispos 27:1214-1219
36. Katori M, Buelow R, Ke B, et al (2002) Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway. Transplantation 73:287-292
37. Blumenthal SB, Kiemer AK, Tiegs G, et al (2005) Metalloporphyrins inactivate caspase-3 and -8. FASEB J 19:1272-1279
38. Lee YS, Kang YJ, Lee BK, et al (2001) Down-regulation of TNF-a and IL-6 by higenamine is responsible for refunction of infarct size and myocardial ischemic injury in the rat. J Appl Pharmacol 9:167-175
39. Forbes RA, Steenbergen C, Murphy E (2001) Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res 88:802-809
40. Cook SA, Sugden PH, Clerk A (1999) Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res 85:940-949
41. von Harndorf R, Li P, Dietz R (1999) Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99:2934-2941
42. Bredesen D (1995) Neural apoptosis. Ann Neurol 38:839-851
43. Zhang JJ, Chen WW (1985) Protection of the synovial fluid by higenamine. Yao Xue Xue Bao 20:423-426
44. Brouard S, Otterbein LE, Anrather J, et al (2000) Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192:1015-1026